Cannula Market Analysis

Cannula Market Analysis

To get key market trends

  Download Free Sample

Based on product, the cannula market is segmented into cardiac, nasal, dermatology, and others. The cardiac segment is further subdivided into venous, arterial, and cardioplegia. The cardiac segment witnessed the largest revenue size at USD 73.2 million in 2022 and is estimated to witness USD 152.8 million by 2032. Cardiac cannulas provide access to the heart chambers and major blood vessels, allowing for various interventions. They can be inserted into the aorta, superior vena cava, inferior vena cava, and other cardiac structures, enabling delivery or removal of blood, medications, and fluids.

Moreover, some cardiac cannulas are equipped with temperature control features, such as heat exchangers or warmers. These devices allow for precise control of the patient's body temperature during cardiac surgery, which is crucial for maintaining optimal conditions and reducing the risk of complications. Furthermore, an increasing availability of cardiovascular devices along with various other businesses working towards creating novel technology.
 

Cannula market is bifurcated based on the type into neonatal, straight, winged, and others. The straight segment is anticipated to reach at USD 127.9 million by 2032. Straight cannulas are commonly used in conjunction with infusion sets or IV administration sets. These sets include additional components such as tubing, connectors, and control devices, and the straight cannula serves as the entry point for medication or fluid delivery. The compatibility with standard infusion sets makes straight cannulas widely used in healthcare settings.
 

In addition, straight cannulas are generally more cost-effective compared to more specialized or advanced cannulas. They are widely available and come at lower price points, making them suitable for routine medical procedures and healthcare facilities with budget constraints. Therefore, owing to the aforementioned factors straight cannulas are widely used. However, neonatal cannulas are anticipated to grow at highest CAGR at 7.9% by 2032. Increasing awareness regarding neonatal infant care and rising novel product launches.
 

The cannula market is segmented by size into 14G, 16G, 18G, 20G, 22G, 24G, and 26G. The 18G segment dominated the industry accounting for more than 25% market share in 2022 and is estimated to witness USD 88.5 million by 2032. 18G cannulas are considered versatile because they can accommodate a variety of medical procedures and applications. They are commonly used for intravenous (IV) therapy, blood transfusions, and other procedures that require the administration of fluids, medications, or blood products.
 

The 18G size provides an appropriate balance between flow rate and patient comfort for many routine medical interventions. Moreover, the 18G cannulas are widely available in medical settings and are a standard option in many healthcare facilities. Their widespread use has made them familiar to healthcare professionals, which contributes to ease of use and efficient insertion.
 

The cannula market is segmented by material into plastic, metal, and silicone. The plastic segment is estimated to witness significant revenue at USD 190.1 million by 2032. Plastic cannulas are typically made of flexible materials such as polyurethane or polyethylene. This flexibility allows them to bend and conform to the body's contours, making them more comfortable for patients. The softness of plastic cannulas reduces the risk of tissue damage or irritation during insertion and use. Plastic cannulas are typically lighter in weight compared to metal cannulas. This can improve patient comfort, particularly during longer-term use or when multiple cannulas are needed. Additionally, plastic cannulas are generally more cost-effective, making them a preferred choice in healthcare settings with budget constraints.
 

The cannula market is segmented by end-use into hospitals, ambulatory surgical centers, specialty centers, and others. Hospitals segment dominated the industry accounting for more than 49% market share in 2022 and is estimated to witness USD 167.9 million by 2032. Cannulas play a crucial role in emergency and critical care settings, where prompt and reliable access to the patient's circulatory system is essential. They enable the rapid administration of life-saving medications, fluids, or blood products in emergency situations or during resuscitation efforts, will result in hospitals dominating the cannula industry. Furthermore, improved research and diagnosis in hospital laboratories, as well as increased disposable income in developed nations, will significantly contribute to the use of cannula in hospitals.
 

U.S. cannula market accounted for USD 61.3 million in 2022 and will grow momentously to reach USD 124.5 million by 2032. The affordability of medical procedures among the target population base and ongoing technological developments are primarily responsible for the development of the industry value. Further, the region's high healthcare spending on health care management and rising disposable income will propel the expansion of the North America industry. Also, the substantial presence of well-established market participants and the favourable regulatory environment result in a number of product approvals and launches, particularly in the U.S.